home / stock / nvzmf / nvzmf news


NVZMF News and Press, Novonesis AS - Class B

Stock Information

Company Name: Novonesis AS - Class B
Stock Symbol: NVZMF
Market: OTC
Website: novonesis.com/en/

Menu

NVZMF NVZMF Quote NVZMF Short NVZMF News NVZMF Articles NVZMF Message Board
Get NVZMF Alerts

News, Short Squeeze, Breakout and More Instantly...

NVZMF - Novozymes A/S Non-GAAP EPS of Euro1.49, revenue of Euro4.16B

2026-02-25 08:46:31 ET More on Novozymes A/S Novozymes A/S (NVZMY) Q4 2025 Earnings Call Transcript Novozymes A/S 2025 Q4 - Results - Earnings Call Presentation Seeking Alpha’s Quant Rating on Novozymes A/S Historical earnings data for Novozymes A/S ...

NVZMF - Novozymes A/S (NVZMY) Q4 2025 Earnings Call Transcript

2026-02-25 07:31:36 ET Novozymes A/S (NVZMY) Q4 2025 Earnings Call February 25, 2026 3:00 AM EST Company Participants Tobias Björklund - Head of Investor Relations Ester Baiget - President & CEO Rainer Lehmann - Executive VP & CFO Henrik Nielsen ...

NVZMF - Novonesis delivered strong organic sales growth of 7% in 2025

COPENHAGEN, Denmark – February 26, 2026. Novonesis delivered strong organic sales growth of 7% and an adjusted EBITDA margin of 37.1% in 2025. The company expects a good start to 2026 and a good year overall.  Ester Baiget, President & CEO:  “In 2025, we continu...

NVZMF - Novozymes A/S reports Q3 results

2025-11-06 15:00:11 ET More on Novozymes A/S Novozymes A/S (NVZMY) Q3 2025 Earnings Call Transcript Novozymes A/S 2025 Q3 - Results - Earnings Call Presentation Novonesis A/S (NVZMF) Q2 2025 Earnings Call Transcript Seeking Alpha’s Quant Rating on Novo...

NVZMF - Novozymes A/S (NVZMY) Q3 2025 Earnings Call Transcript

2025-11-06 06:36:09 ET Novozymes A/S (NVZMY) Q3 2025 Earnings Call November 6, 2025 3:00 AM EST Company Participants Tobias Björklund - Head of Investor Relations Ester Baiget - President & CEO Rainer Lehmann - Executive VP & CFO Claus Fuglsang -...

NVZMF - Novonesis delivered 8% organic sales growth in the first nine months of 2025

Novonesis delivered 8% organic sales growth in the first nine months of 2025 and narrowed full-year outlook upwards. COPENHAGEN, Denmark – November 6, 2025. Novonesis delivered 8% organic sales growth in the first nine months of 2025. Full-year outlook is narrowed upwards to 7-8%, prev...

NVZMF - Noma and Novonesis partner to scale deliciousness

Noma and Novonesis partner to scale deliciousness Noma, hailed as one of the world’s best restaurants, is joining forces with Novonesis, the global leader in biosolutions, to take deliciousness to the next level. Together, they’re fusing culinary craft with biology to create...

NVZMF - Novonesis Hosts National Flagship Manufacturing Day Event at North America Headquarters

Franklinton, NC, Oct. 06, 2025 (GLOBE NEWSWIRE) -- Novonesis , a global leader in biosolutions, welcomed hundreds of local students, educators, and community leaders to its facilities in Salem, Virginia; West Allis and Madison, Wisconsin; and its North American headquarters in Franklinton...

NVZMF - Novonesis and Novo Nordisk will explore new solutions to improve metabolic health

Novonesis and Novo Nordisk join forces in a new research collaboration to explore solutions that seek to preserve and optimize metabolic health and well-being for people. COPENHAGEN, Denmark – September 8, 2025. Novonesis and Novo Nordisk has entered a research partnership to exp...

NVZMF - Biosolutions could create more than 600,000 jobs and unlock hundreds of billions in growth for Europe

Biosolutions could create more than 600,000 jobs and unlock hundreds of billions in growth for Europe A new report reveals that biosolutions could generate EUR 133 billion in economic gains and create over 600,000 jobs across all of Europe by 2035. But without urgent policy leadership and...

Next 10